Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: a non-deletional mutation or polymorphism?
Ropero P, González FA, Nieto JM, Villegas A, Sevilla J, Pérez G, Alonso JM, Recasens V, Abio M, Vagace JM, Vanegas RJ, González Fernández B, Martínez R. Ropero P, et al. Among authors: recasens v. J Clin Pathol. 2020 Jan;73(1):14-16. doi: 10.1136/jclinpath-2019-206004. Epub 2019 Aug 21. J Clin Pathol. 2020. PMID: 31434698
Does size matter? Two new deletions in the HBB gene cause β0-thalassemia.
Ropero P, González Fernández FA, Nieto JM, Recasens V, Montañés Á, Murúzabal MJ, Sarasa M, Fernández C, Villegas A, Benavente CC. Ropero P, et al. Among authors: recasens v. Ann Hematol. 2022 Jul;101(7):1465-1471. doi: 10.1007/s00277-022-04837-4. Epub 2022 Apr 25. Ann Hematol. 2022. PMID: 35467101
Sickle cell disease associated with thalassemia; description of a rare mutation.
Mariño SFP, Gradilla PR, González Fernández FA, Martínez AMV, Martínez SM, Bartol Puyal FA, Palomar EV, Otal CI, Ciordia BC, Marsal JOC, Bakali Badesa S, García Ortego JA, Martínez AG, Gracia MÁM, Recasens V. Mariño SFP, et al. Among authors: recasens v. Clin Biochem. 2021 Aug;94:80-82. doi: 10.1016/j.clinbiochem.2021.04.016. Epub 2021 Apr 24. Clin Biochem. 2021. PMID: 33901469
Autoimmune haemolytic anaemias: A retrospective study of 93 patients.
Gutiérrez Jomarrón I, López Rubio M, Morado Arias M, Arrizabalaga B, de la Iglesia S, Beneitez D, Sáez MI, Cervera A, Recasens V, Herrera A, Villegas AM; Grupo Español de Eritropatología. Gutiérrez Jomarrón I, et al. Among authors: recasens v. Med Clin (Barc). 2020 May 8;154(9):331-337. doi: 10.1016/j.medcli.2019.06.024. Epub 2019 Sep 2. Med Clin (Barc). 2020. PMID: 31488259 English, Spanish.
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
García-Marco JA, Jiménez JL, Recasens V, Zarzoso MF, González-Barca E, De Marcos NS, Ramírez MJ, Parraga FJP, Yañez L, De La Serna Torroba J, Malo MDG, Ariznavarreta GD, Persona EP, Guinaldo MAR, De Paz Arias R, Llanos EB, Jarque I, Valle MDCF, Tatay AC, De Oteyza JP, Martin EMD, Fernández IP, Martinez RM, Costa MAA, Champ D, Suarez JG, Díaz MG, Ferrer S, Carbonell F, García-Vela JA; GELLC Study Group. García-Marco JA, et al. Among authors: recasens v. Haematologica. 2019 Nov;104(11):2249-2257. doi: 10.3324/haematol.2018.204891. Epub 2019 Mar 19. Haematologica. 2019. PMID: 30890600 Free PMC article.
Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial.
Mateo-Gallego R, Lacalle L, Pérez-Calahorra S, Marco-Benedí V, Recasens V, Padrón N, Lamiquiz-Moneo I, Baila-Rueda L, Jarauta E, Calmarza P, Cenarro A, Civeira F. Mateo-Gallego R, et al. Among authors: recasens v. J Clin Lipidol. 2018 Sep-Oct;12(5):1190-1198. doi: 10.1016/j.jacl.2018.06.017. Epub 2018 Jul 4. J Clin Lipidol. 2018. PMID: 30049591 Clinical Trial.
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
González-Rincón J, Garcia-Vela JA, Gómez S, Fernández-Cuevas B, Nova-Gurumeta S, Pérez-Sanz N, Alcoceba M, González M, Anguita E, López-Jiménez J, González-Barca E, Yáñez L, Pérez-Persona E, de la Serna J, Fernández-Zarzoso M, Deben G, Peñalver FJ, Fernández MC, de Oteyza JP, Andreu MÁ, Ruíz-Guinaldo MÁ, Paz-Arias R, García-Malo MD, Recasens V, Collado R, Córdoba R, Navarro-Matilla B, Sánchez-Beato M, García-Marco JA. González-Rincón J, et al. Among authors: recasens v. PLoS One. 2021 Sep 10;16(9):e0257353. doi: 10.1371/journal.pone.0257353. eCollection 2021. PLoS One. 2021. PMID: 34506616 Free PMC article.
20 results